IE
STTK icon

Israel Englander’s Shattuck Labs STTK Stock Holding History

Israel Englander’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Sell
194,008
-569,737
-75% -$3.55M ﹤0.01% 4125
2026
Q1 		$4.91M Buy
763,745
+286,337
+60% +$1.36M ﹤0.01% 2967
2025
Q4 		$1.74M Sell
477,408
-213,493
-31% -$509K ﹤0.01% 4062
2025
Q3 		$1.65M Sell
690,901
-152,355
-18% -$186K ﹤0.01% 4222
2025
Q2 		$668K Buy
843,256
+540,658
+179% +$524K ﹤0.01% 4702
2025
Q1 		$287K Buy
302,598
+101,384
+50% +$125K ﹤0.01% 5121
2024
Q4 		$243K Buy
201,214
+54,322
+37% +$67.3K ﹤0.01% 5193
2024
Q3 		$513K Buy
146,892
+49,980
+52% +$186K ﹤0.01% 4816
2024
Q2 		$374K Sell
96,912
-515,472
-84% -$4.19M ﹤0.01% 4782
2024
Q1 		$5.47M Buy
612,384
+601,738
+5,652% +$5.51M ﹤0.01% 2774
2023
Q4 		$75.9K Sell
10,646
-42,270
-80% -$115K ﹤0.01% 5399
2023
Q3 		$80.4K Sell
52,916
-3,264
-6% -$7.45K ﹤0.01% 5389
2023
Q2 		$175K Sell
56,180
-3,100
-5% -$8.99K ﹤0.01% 5170
2023
Q1 		$174K Sell
59,280
-34,839
-37% -$123K ﹤0.01% 5228
2022
Q4 		$216K Sell
94,119
-88,364
-48% -$221K ﹤0.01% 5289
2022
Q3 		$493K Sell
182,483
-81,542
-31% -$306K ﹤0.01% 4987
2022
Q2 		$1.07M Buy
264,025
+181,036
+218% +$655K ﹤0.01% 4299
2022
Q1 		$354K Sell
82,989
-398,745
-83% -$2.26M ﹤0.01% 5407
2021
Q4 		$4.1M Buy
481,734
+347,202
+258% +$4.78M ﹤0.01% 3108
2021
Q3 		$2.74M Buy
+134,532
New +$2.88M ﹤0.01% 3548
2021
Q2 		– Sell
-14,234
Closed -$416K – 7079
2021
Q1 		$416K Buy
+14,234
New +$598K ﹤0.01% 4975

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $217M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Israel Englander's STTK Position: Q2 2026 in Review

Israel Englander reduced its Shattuck Labs (STTK) stake by 75% in Q2 2026, selling an estimated $3.55M and leaving 194,008 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #4125.

Israel Englander first reported a position in STTK in Q1 2021 and has held it in 21 quarters since. The position peaked at $5.47M in Q1 2024. 99 funds tracked by Wall St. Rank hold STTK as of Q2 2026.

  • Israel Englander held 194,008 shares of Shattuck Labs worth $1.35M as of Q2 2026.
  • Israel Englander sold 569,737 Shattuck Labs shares in Q2 2026, an estimated $3.55M.
  • Shattuck Labs made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4125 holding.
  • Israel Englander first reported a position in Shattuck Labs in Q1 2021 and has held it in 21 quarters since.
  • Israel Englander's Shattuck Labs position peaked at $5.47M in Q1 2024.
  • 99 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.